New eczema treatment approved for younger patients

to treat it, but until recently, children from six months to age five who weren't responding to those medications, didn't have many other options — until now. You would never know by looking at her now, but five-year-old Ariah was often miserable with a continuous rash on her face and body that left her scratching and itching and not able to sleep.

After trying every possible ointment and remedy available, Dahliwa was out of options — until she found Dr. Amy Paller.Ariah became part of a clinical trial for a drug that was being tested out for the first time on the youngest of eczema patients.You've probably heard the commercials for Dupixent. It's been available for adults since 2017, but was only recently approved for those under five years old."These kids are just miserable.

"Sixteen percent have moderately severe disease so that one-third of children who just don't respond adequately to the topical agents, we've always had to move up to the next levels and that level for the most part was going to immunosuppressive medicines. We don't like to use oral steroids because they have so many side effects," said Dr. Paller.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Monkeypox treatment enters Phase 3 clinical trialTPOXX — a smallpox treatment that's become a backstop for patients who test positive for monkeypox in the U.S. — is going into a Phase 3 clinical trial to test its effectiveness. Lmfaoooo come on now this isn’t real
Source: axios - 🏆 302. / 63 Read more »

Tiny 'Drug Factory' Implants Can Eradicate Tumors in Mice in Just DaysScientists have managed to stop advanced-stage cancers in mice through the use of implanted 'drug factories' – and the new type of treatment only takes a few days to become effective.
Source: ScienceAlert - 🏆 63. / 68 Read more »